Preclinical medical device startup based in Cheshire, UK. Developing a ground-breaking electric field therapy implant to treat aggressive brain tumours.
Cheshire, UK
Joined September 2019
- Tweets245
- Following359
- Followers242
- Likes155
Pinned Tweet
We’ve secured £4.5m in investment and grant funding to advance GRACE, our fully implantable electric field therapy for glioblastoma, into clinical studies.
Thank you to our investors, funders, and partners for the support.
Fully story here: lnkd.in/dgYS8fge
QV Bioelectronics announces a leadership update 🚀
Carl Daintree is now CEO, bringing strong experience in medtech 🧬
Co-founder Chris Bullock becomes CTO, focusing on advancing our bioelectronic platform for brain tumours
Read in full 👇
qvbio.co.uk/leadership-updat…
🚨 Big news at QV Bioelectronics!
We've been awarded £1.2M by @innovateuk as part of the Biomedical Catalyst to support preparations for a first-in-human trial of GRACE.
Full Press Release: shorturl.at/kxOtX
#BiomedicalCatalyst #InnovateUKFunded
⏳ We’ve got some exciting news to share tomorrow at QV Bioelectronics.
Looking forward to sharing more very soon.
Excited to welcome Carl Daintree as QV's new COO! 🚀
Carl brings expertise across medtech, pharma & biotech. At 30 Technology, he led products from prototype to exit, driving clinical studies & market strategy.
Thrilled to have him as we advance brain tumour treatment! 🧠
QV Bioelectronics retweeted
After a rigorous selection process, 5 innovative start-ups are pitching their ground-breaking solutions in the brain health space! 🧠💡
🎤 @qvbio , BrainTale, CREATe Therapeutics, Paperbox and @Rebrain_eu take the stage for this pitch competition in front of five jury members!
🚀 Big News from QV Bioelectronics! 🚀
We’re excited to announce breakthrough pre-clinical results for our Glioblastoma therapy!
💼Now Raising Series A
More details in our press release below🔗
rb.gy/z446y3
QV Bioelectronics retweeted
@qvbio secures £343,000 from Innovate UK’s Cancer Therapeutics programme to develop a new treatment for childhood brain tumours
🚀 Exciting news! QV has secured £343,000 from Innovate UK to develop the world’s first fully implantable Electric Field Therapy (EFT) device for childhood brain cancers. 🎗️
This supports early-stage development & testing, advancing new options and expanding our portfolio.
March is Brain Tumor Awareness Month. Our startup is dedicated to innovation in this field, emphasising the critical need for community support and groundbreaking approaches. #BrainTumorAwareness
QV Bioelectronics retweeted
Our @AlderleyPark campus offers state-of-the-art labs where ideas can flourish. Just look at these pics of @qvbio’s new space!😍
💡Growing their business at #AlderleyPark, QV Bio is a start-up developing surgically implantable #medical devices to treat malignant brain tumours🔬
QV Bioelectronics retweeted
@InnovateUK & @UKinTX hosted @michelledonelan on her visit to @TXMedCenter to meet the latest cohort of UK-based #DigitalHealth & #Medical device startups participating in the TMC Innovation accelerator, part of Innovate UK's Global Incubator Programme.
⚕️ow.ly/5vwI50Q8EP1
ALT Photo montage of the Right Honourable Michelle Donelan MP, SoS, meeting with UK medtech and health innovation businesses participating in the TMC Innovation accelerator as part of the Innovate UK Global Incubator Programme.
We will be at the 28th Annual Meeting for the @NeuroOnc this week at the @VanConventions !🍁
Ryan Purdy and Tomisin Olukoga will be presenting our exciting pre-clinical work using Electric Field Therapy (EFT). 💬
QV Bioelectronics retweeted
Now Presenting: Christopher Bullock of @qvbio (Cheshire, UK). They are developing the world’s first implantable electric field therapy device to treat aggressive brain cancers.
Are you staying informed?
bit.ly/3G0kLGa
QV Bioelectronics retweeted
🎉Presenting in the #Oncology Therapeutic Category at Innovation Summit San Francisco 2023 is Presenting Company QV Bioelectronics (@qvbio) with CEO Christopher Bullock.
🎉 Welcome to #InnovationSF23, Chris and the QV Bioelectronics team! We are delighted to have you.
QV Bioelectronics retweeted
@qvbio and @IncubateBio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma
qvbio.co.uk/qv-bioelectronic…
QV Bioelectronics retweeted
Our IDH mutant glioma heterogeneity paper with @hoheyn is out in @CellRepMed. A wonderful collective effort by @Enblacar, Ashwin, Inma, and @JuanCNieto1. Special thanks to Matthias and Luigi. Looking forward to expanding on this work!
cell.com/cell-reports-medici…
Excited to be one of the presenting companies at #LSIEurope23
In just six weeks over 150+ of the most exciting emerging companies will take the stage at #LSIEurope23
From seed to growth-stage, pre-revenue to commercial, Europe to the USA, robotics and digital surgery to neuromodulation, LSI Europe '23 will be the epicenter of Medtech.
🌞 Exciting News: Welcome Michaela Baek, Our New Summer Intern at QV Bioelectronics! 🌱
Michaela, an aspiring biologist, is eager to deepen her understanding of the therapy development process, while also honing her technical skills within a medical devices company.
#Welcome
QV Bioelectronics retweeted
📢 Exciting news as @ukCPI Enterprises invest in @qvbio's GRACE medical device which could increase long-term survival for people with the most common and aggressive type of #braintumours.
Fantastic to see two @BW_SciTech customers working together🔄 🤝
alderleypark.co.uk/news/2023…